Department of Pharmaceutical Sciences School of Applied Sciences De Montfort University Leicester LE1 9BH UK.
Mediators Inflamm. 1995;4(1):55-9. doi: 10.1155/S096293519500010X.
Possible links have been investigated between activation of protein kinase C (PKC) and endothelin (ET) production by small blood vessels. Perfusion pressures were recorded from rat isolated mesenteric artery, with or without the small intestine attached, before and after addition to the perfusate of either ET-1, ET-3 or the PKC activator 12-deoxyphorbol 13-phenylacetate (DOPPA). Rises in perfusion pressure in response to ET-1 (10(-8) M)or DOPPA (10(-6) M) were reduced significantly by pre-treatment with either the ET(A) receptor antagonist PD151242 (10(-6) M) or the PKC inhibitor Ro 31-8220 (10(-6) M). ET-3 (10(-8) M) had a significant, albeit small, effect only when the gut was still attached to the mesentery. Inthis latter preparation ET-1 and DOPPA increased the permeability of villi microvessels to colloidal carbon in the perfusate. This effect of DOPPA was reduced by pre-treatment with either PD151242 or Ro 31-8220, but the effects of ET-1 were reduced significantly only by Ro 31-8220. ET-3 (10(-8) M) was without effect. The results suggest a possible bi-directional link between ET(A) receptors and PKC in the intestinal vasculature.
已经研究了蛋白激酶 C(PKC)的激活与小血管内皮素(ET)产生之间的可能联系。在向灌流液中加入 ET-1、ET-3 或 PKC 激活剂 12-脱氧佛波醇 13-苯乙酸酯(DOPPA)之前和之后,从大鼠分离的肠系膜动脉(有或没有附着的小肠)中记录灌注压。对 ET-1(10(-8)M)或 DOPPA(10(-6)M)的灌注压升高的反应,通过用 ET(A)受体拮抗剂 PD151242(10(-6)M)或 PKC 抑制剂 Ro 31-8220(10(-6)M)预处理而显著降低。只有当肠道仍附着在肠系膜上时,ET-3(10(-8)M)才有明显的影响,尽管很小。在后一种制剂中,ET-1 和 DOPPA 增加了灌流液中小绒毛微血管对胶体碳的通透性。PD151242 或 Ro 31-8220 的预处理均可降低 DOPPA 的这种作用,但只有 Ro 31-8220 可显著降低 ET-1 的作用。ET-3(10(-8)M)无作用。结果表明,在肠道血管中,ET(A)受体和 PKC 之间可能存在双向联系。